5 Stocks Insiders are Buying Right Now

According to our research, stocks bought by insiders demonstrate a small outperformance effect, which seems logical given the fact that insiders are the most knowledgeable about their respective companies’ prospects. Although insider purchases in and of themselves would not be enough reason to buy a stock, we think they can serve as useful indicators (such as valuation ratios) when screening for attractive investments. Below are five companies whose stocks insiders have purchased recently.

Martin Shkreli, the CEO of Retrophin, Inc. (NASDAQ:RTRX), has bought shares of his company on a regular basis over the past year in varying amounts, with the most recent disclosure in early April showing a purchase of 10,800 shares. Currently, he is the second largest shareholder, with almost 3 million shares, or a 12% stake, valued at roughly $69 million. Retrophin is a $388.4 million market cap biopharmaceutical company that engages in the discovery, development, and commercialization of orphan drugs for the treatment of rare and life-threatening diseases. In addition to insider trading filings, we also maintain a database of 13F filings from hundreds of hedge funds. We use these filings to develop a small-cap investing strategy based on stocks popular with hedge funds, which has generated more than 37 percentage points of outperformance versus the S&P 500 from September 2013 through January 2014 (click here for more details). According to recent filings, Joseph Edelman of Perceptive Advisors was also bullish on Retrophin.

insider trading

 

Ronald Sargent, Chairman and CEO of Staples Inc. (NASDAQ:SPLS), disclosed today that he bought 8,500 shares of the company. With 2.2 million shares, he is the largest shareholder in the $7.7 billion market cap operator of office product superstores. Hedge fund managers that share his bullish view on the stock include Richard Pzena of Pzena Investment Management, Russell Hawkins of Hawkins Capita and Ric Dillon of Diamond Hill Capital.

Maher Albitar, the Chief Medical Officer of Neogenomics Inc. (NASDAQ:NEO), disclosed in late March that he purchased 14,492 shares of the company, bringing his stake to 48,492 shares, or a 0.1% stake. Neogenomics is a $177.8 million market cap company that operates a network of cancer-focused testing laboratories providing genetic and molecular testing services. Hedge fund managers that own the stock include Carl Wiese of Grow Partners, Ken Griffin of Citadel Investment Group and Israel Englander of Millennium Management.

R Lesli Gilbert, an executive vice president of Store and Operations at Wet Seal Inc. (NASDAQ:WTSL), disclosed purchasing 10,000 shares of the company, for a total stake of 99,929 shares. Wet Seal is a $102.4 million market cap multi-channel retailer of apparel and accessories for female consumers. Greg Taxin of Clinton Group, Joe Huber of Huber Capital Management and Cliff Asness of AQR Capital Management are the three largest shareholders of the company among the hedge funds we track.

Over a six week period beginning in mid-March, Willem Mesdag, a director at Destination XI Group (NASDAQ:DXLG) as well as the manager of Red Mountain Capital, disclosed purchasing a total of 2.7 million shares in the company, bringing his total stake to 7.5 million shares and making him the largest shareholder among the hedge fund managers we track. Destination XI is a $280.8 million market cap specialty retailer of big and tall mens apparel in the U.S., England and Canada. Other hedge fund managers that are bullish on the company include Glenn Krevlin of Glenhill Advisors, Christopher Shackelton and Adam Gray of Coliseum Capital and Phil Frohlich of Prescott Group Capital Management.

Disclosure: none

Recommended Reading:

Two Healthcare Companies That Insiders Have Bought Recently

Two Oil-Related Services Stocks With Multiple Insider Purchases

Insiders Buy Shares of Methode Electronics Inc. (MEI) & Kratos Defense & Security Solutions, Inc (KTOS)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!